Liver Cancer Institute Zhongshan Hospital

Sun Yat-sen - Wikipedia, The Free Encyclopedia
Sun Yat-sen (/ ˈ s ʊ n ˈ j ɑː t ˈ s ɛ n In 1886 Sun studied medicine at the Guangzhou Boji Hospital under the Christian missionary John G. Kerr. [1] Sun died of liver cancer on 12 March 1925 at the age of 58 at the Rockefeller financed Peking Union Medical College. ... Read Article

Center For Cancer Research: Chinese Interactions
Center for Cancer Research: Chinese Interactions Lee J. Helman, Beijing Genome Institute Beijing University First Hospital Beijing University of Technology Liver Cancer Institute Nanjing Medical University ... Read Document

LIVER CANCER Down-regulation Of PTEN Expression Due To Loss ...
• LIVER CANCER • Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines Dong-Zhu Ma, Zhen Xu, MHCC-97H and MHCC-97L kindly provided by Liver Cancer Institute of Zhongshan Hospital, Fudan University (Shanghai, ... Get Doc

Metastasis Of Hepatic Cancer - Home - Springer
12 Metastasis of Hepatic Cancer Zhaoyou Tang Key Laboratory of Carcinogenesis and Cancer Invasion of Fudan University, Ministry of Education; Liver Cancer Institute and Zhongshan Hospital of Fudan ... Fetch Document

Analysis Of The Clinicopathological Features Of ...
Liver Cancer Institute, Zhongshan Hospital. Fudan University, 200032, Shanghai, China Email: xiajinglin@hotmail.com. INTRODUCTION. Hepatocellular carcinoma (HCC) is one of the most . common malignancies in China, which accounts for ... View Document

Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor ...
Neddylation-Cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer Junfeng Xu1,2,3, Lihui Li1,2, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, Zhongshan Hospital (Fudan University, Shanghai, China) in 2014. ... Access Doc

Conversion To Sirolimus Immunosuppression In liver ...
Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience Jian Zhou, Feng He, Yu-Qi Wang, Zhao-You Tang, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai 200032, China ... Fetch Here

Caveolin-1 Confers Resistance Of Hepatoma Cells To Anoikis By ...
Liver Cancer Institute, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, (China) and Minhang District Central Hospital, Fudan University, 170 Xinsong Road, Minhang District, Shanghai 201199 (China) ... Doc Viewer

Expression Profiling Suggested A Regulatory Role Of Liver ...
Expression Profiling Suggested a Regulatory Role of Liver-enriched Transcription Zhongshan Hospital, Shanghai 200032, China [Y. J.]; average 1165 genes were differentially expressed in paired cancer and distal nontumorous liver tissues. However, ... View Full Source

List Of hospitals In China - Wikipedia, The Free Encyclopedia
List of hospitals in China This is a list of hospitals in China. [1] As of Zhongshan Hospital; Huashan Hospital, also of Red Cross Society of China; Tianjin Medical University Cancer Institute and Hospital; ... Read Article

The Functional Impairment Of HCC-infiltrating γδ T Cells ...
The functional impairment of HCC-infiltrating cd T cells, partially mediated by regulatory T cells in a TGFb- and IL-10 Jian-Jun Jin2, Jia Fan1,⇑, Shuang-Jian Qiu1,2,⇑ 1Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer ... Fetch Doc

Liver cancer Initiation Is Controlled By AP-1 Through SIRT6 ...
Liver cancer initiation is controlled by AP-1 through Dr. Bohr-Gasse 7, 1030 Vienna, Austria. 5Liver Cancer Institute, Zhongshan Hospital, Fudan University, Fenglin Road 180, 200032 Shanghai, China. 6Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, 8036 Graz, Austria. ... Retrieve Doc

Evaluation Of Midkine As A Diagnostic Serum Biomarker In ...
1 Liver Cancer Institute and Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China. Liver cancer is the fifth most common cancer but the second leading cause of cancer death in men worldwide ... Return Doc

CONSIDERATION OF ROLE OF RADIOTHERAPY FOR LYMPH NODE ...
CLINICAL INVESTIGATION Liver CONSIDERATION OF ROLE OF RADIOTHERAPY FOR LYMPH NODE METASTASES IN PATIENTS WITH HCC: Departments of *Radiation Oncology and ‡Radiology, and †Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China ... Document Retrieval

Capecitabine Inhibits Postoperative Recurrence And Metastasis ...
Capecitabine Inhibits Postoperative Recurrence and Metastasis after Liver Cancer Resection in Nude Mice with Relation Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China ABSTRACT ... Read Content

301 Military Hospital - Wikipedia, The Free Encyclopedia
301 Military Hospital; Geography; Location: 4th Ring Road, Beijing, People's Republic of China: The China PLA General Hospital was formerly the second clinical institute affiliated to Peking Union Medical College, which was changed in October, ... Read Article

EpCAM And A-Fetoprotein Expression Defines Novel Prognostic ...
Patients who underwent radicalresection at the Liver Cancer Institute and Zhongshan Hospital(Fudan University, Shanghai, China) and the study was approved by the InstitutionalReview Board of the Liver Cancer Institute. ... Read More

NITRIC OXIDE SYNTHASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR ...
NITRIC OXIDE SYNTHASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HEPATOCELLULAR CARCINOMA AND THE Liver Cancer Institute and Zhongshan Hospital Fudan Medical Center, who received curative resection in the Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical ... Access Doc

Peritumoral Cbl Is A Strong Independent Prognostic Marker ...
January 1999 to December 2003 respectively, in the Liver Cancer Institute, Zhongshan Hospital, Shanghai, China. The patient enrollment criteria and postsurgical patient surveillance were similar to those specified in our previous reports [8]. ... View This Document